What is the RPRX stock price prediction for next 2 weeks?

According to our price prediction algorithm,Royalty Pharma plc (RPRX) price will be around $45.09 in the next 2 weeks. This means it will decrease by -0.5945767195767202 from the last closing price. This prediction may vary from other time period filters for RPRX stock.

What can be the highest Possible price of RPRX stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, RPRX can achieve the highest price of $45.84 which is 1.0543292910097053 higher than last closing price. This prediction may vary from other time period filters for RPRX stock.

What can be the lowest Possible price of RPRX stock in next 2 weeks?

As per the forecast and algorithmic analysis, RPRX stock price can be as low as $44.35 which is -2.222689997721034 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for RPRX stock.

Will RPRX stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that RPRX stock will lose-0.5945767195767202 in the next 2 weeks. This prediction may vary from other time period filters for RPRX stock.

What is RPRX stock last closing price?

Last closing price of RPRX stock was $45.36.

What is RPRX stock price prediction?

RPRX stock price prediction means predicting the future closing prices of RPRX stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of RPRX stock in a certain time period.

How we predict RPRX stock future prices?

If you are searching for RPRX stock forecast, analysis or price prediction, then you might be wondering what Royalty Pharma plc (RPRX) will do in the future. Our RPRX price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This RPRX price prediction will likely answer most of your questions.

How frequent we update RPRX stock predictions?

We are updating the forecasts for the RPRX stock on daily basis.

Is using ML forecasting for RPRX stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for RPRX stock same for all the time periods?

No, the prediction for RPRX stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Royalty Pharma plc Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$45.36-0.11%Since 2 Weeks

Predicted Price$45.09-0.59%For 2 Weeks

Upper Predicted Price$45.841.05%For 2 Weeks

Lower Predicted Price$44.35-2.22%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of RPRX will decline by -0.59% over the next 2 Weeks and hit $45.09 by Friday, April 3, 2026. In that time frame, RPRX's share price is expected to range between $44.35 and $45.84.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Apr 3, 2026	44.20	44.94	45.71
Apr 2, 2026	44.08	44.81	45.49
Apr 1, 2026	44.33	44.94	45.65
Mar 31, 2026	44.55	45.16	45.78
Mar 30, 2026	44.49	45.10	45.68
Mar 27, 2026	44.56	45.15	45.72
Mar 26, 2026	44.43	45.02	45.58
Mar 25, 2026	44.60	45.15	45.67
Mar 24, 2026	44.80	45.37	45.90
Mar 23, 2026	44.75	45.30	45.87

RPRX shares fell -0.37% in Friday, March 20, 2026's trading session, dropping from a previous close of $45.53 to move at $45.36. The stock demonstrated notable intraday movement (see RPRX's key stats for a full breakdown), fluctuating between $44.75 and $46.10, a +3.02% trading range. While recent weeks have seen some volatility, RPRX has managed to secure a -1.05% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 7.94M shares changing hands, 5.18M more than the previous session. This amounted to $360.10M in total market activity.

Will RPRX Continue Its Upward Trend?

According to analyst ratings and projections for RPRX, Royalty Pharma plc shares are anticipated to increase by +0.76%, potentially reaching $45.71 per share by April 3, 2026. Short-term technical indicators currently suggest a neutral sentiment for RPRX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 19 positive trading days within the past 30 sessions. Based on the RPRX stock forecast, now is a good time to buy RPRX stock because its current trading price is +0.93% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on RPRX covering social and institutional perspectives.

RPRX Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into RPRX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 43.98% to 55.00%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 58.73%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 58.00%, maintains a neutral outlook for the long term. Insights into RPRX's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Royalty Pharma Short-Term Forecasts

RPRX Forecast For Next 5 Days

Our algorithm anticipates Royalty Pharma (RPRX) stock could hit $44.55 by Mar 27, 2026. This represents a -1.78% fall from today's price, following a -2.91% change over the past five days.

RPRX Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Royalty Pharma plc (RPRX) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $45.54, which would mean a +0.40% increase from the current price of $45.36. Projections for this period range from a high of $47.65 to a low of $43.67.

RPRX Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Royalty Pharma's price over the next three months point to a rise. RPRX stock is expected to peak at $49.31 on Apr 24, 2026 after potentially dipping to $42.54 on Mar 31, 2026. On average, RPRX is likely to trade around $46.12 in the coming 90 days.

Royalty Pharma Stock Forecast 2025

Based on our predictive models, Royalty Pharma (RPRX) is expected to trade between $42.54 and $50.32 throughout 2026. This would result in an average price of $46.65, potentially offering investors a +2.84% return from current levels.

Royalty Pharma plc Monthly Forecast 2026–2027

March 2026

According to our latest forecast models, Royalty Pharma plc (RPRX) is positioned to show a strong performance in March 2026. The price is predicted to move between $42.54 and $46.63, settling at an average of $44.42. This could translate to a -2.07% loss.

April 2026

Based on current market signals, Royalty Pharma plc is projected to trend april 2026. We forecast a trading range from $42.99 to $49.31, with a likely average price of $45.98. Investors could expect a potential return of +1.37%.

May 2026

Our predictive algorithms indicate Royalty Pharma plc stock may see a shift in May 2026. The expected range spans $44.40–$48.95, with an average target of $46.61. This represents a positive outlook and a possible gain of +2.76%.

June 2026

Analyzing established trends, Royalty Pharma plc looks set to move in June 2026. Projections place the stock between $43.72 and $48.69, averaging around $46.26. This suggests a +1.98% gain from current levels.

July 2026

Market indicators suggest Royalty Pharma plc could experience notable changes during July 2026. Prices could fluctuate within $44.04 to $48.77, with a midpoint forecast of $46.57. The stock might deliver a +2.67% gain.

August 2026

Forecasting for August 2026, models estimate that Royalty Pharma plc may undergo key fluctuations. If trends hold, the stock might trade between $43.14 and $49.03, averaging $46.08. This signals a positive trajectory with potential returns around +1.59%.

September 2026

According to our latest forecast models, Royalty Pharma plc (RPRX) is positioned to show a strong performance in September 2026. The price is predicted to move between $44.03 and $50.32, settling at an average of $47.03. This could translate to a +3.68% gain.

October 2026

Based on current market signals, Royalty Pharma plc is projected to trend october 2026. We forecast a trading range from $43.26 to $49.72, with a likely average price of $47.42. Investors could expect a potential return of +4.54%.

November 2026

Our predictive algorithms indicate Royalty Pharma plc stock may see a shift in November 2026. The expected range spans $44.60–$49.58, with an average target of $47.07. This represents a positive outlook and a possible gain of +3.77%.

December 2026

Analyzing established trends, Royalty Pharma plc looks set to move in December 2026. Projections place the stock between $45.26 and $49.79, averaging around $47.46. This suggests a +4.63% gain from current levels.

January 2027

Market indicators suggest Royalty Pharma plc could experience notable changes during January 2027. Prices could fluctuate within $44.11 to $49.74, with a midpoint forecast of $46.96. The stock might deliver a +3.53% gain.

February 2027

Forecasting for February 2027, models estimate that Royalty Pharma plc may undergo key fluctuations. If trends hold, the stock might trade between $45.25 and $51.22, averaging $48.04. This signals a positive trajectory with potential returns around +5.91%.

March 2027

According to our latest forecast models, Royalty Pharma plc (RPRX) is positioned to show a strong performance in March 2027. The price is predicted to move between $46.38 and $50.60, settling at an average of $48.34. This could translate to a +6.57% gain.

RPRX's history of dividends and stock splits also plays a role in long-term investor confidence.